Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
US11318113B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 13, 2020 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | May 13, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.